CEO Fabio Fin discusses the company's monitoring of new DL regulations, noting minimal impact due to existing strategies. CFO Philippe Negron highlights cost reduction opportunities. CEO Fin also emphasizes growth in medical courses, student retention strategies for financial returns, and pricing strategies for hybrid courses.